Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

221 Views

Poster Session: New Antimicrobial Drug Development

518 - Characterization of colistin-resistant (COL-R) Acinetobacter baumannii calcoaceticus complex (ABC) isolates from a recent, global Phase 3 trial (ATTACK)

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

SM

Samir Moussa, PhD

Principal Scientist
Entasis Therapeutics
Waltham, Massachusetts, United States

Presenting Author(s)

Sarah McLeod, PhD (she/her/hers)

Director
Entasis Therapeutics
Waltham, Massachusetts, United States

Co-Author(s)

Alita Miller, PhD

CSO
Entasis Therapeutics
Waltham, Massachusetts, United States